The Union health ministry on Monday reiterated there is no scientific evidence of COVID-19 vaccination causing infertility in men and women and asserted the jabs are safe and effective.
There have been media reports expressing concern regarding infertility due to COVID-19 vaccination among people of reproductive age, the ministry said in a statement.
Over the last few days, certain media reports have highlighted the prevalence of various superstitions and myths in a section of healthcare workers (HCWs) and frontline workers (FLWs) including the nurses, it said.
Such misinformation and rumours were spread during the vaccination drives against polio and measles-rubella too, it added.
The ministry said it has clarified in the FAQs (frequently asked questions) posted on the website that none of the available vaccines affect fertility, as all the vaccines and their constituents are tested first on animals and later on humans to assess if they have any such side effects.
Vaccines are authorised for use only after their safety and efficacy is assured, the statement said.
"Furthermore, in order to curb the prevalent myth regarding infertility due to COVID-19 vaccination, the government of India has clarified that there are no scientific evidences suggesting COVID-19 vaccination can cause infertility in men and women. The vaccines have been found to be safe and effective," it stated.
The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) has recommended the COVID-19 vaccination for all lactating women, terming it as safe with no need to stop or pause breastfeeding before or after the vaccination.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)